Nabiel Mikhail

Nabiel Mikhail

Assiut University

H-index: 38

Africa-Egypt

About Nabiel Mikhail

Nabiel Mikhail, With an exceptional h-index of 38 and a recent h-index of 20 (since 2020), a distinguished researcher at Assiut University, specializes in the field of HIMS.

His recent articles reflect a diverse array of research interests and contributions to the field:

Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B

A Prospective Study for Validation of General Evaluation Score for Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis C Patients

Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD

Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program

Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: A prospective observational study

Reply to: The best predictive model for post-SVR HCC: can it be universal?

Staging practices and breast cancer stage among population-based registries in the MENA region

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response

Nabiel Mikhail Information

University

Position

Dept of Biostatistics and Cancer Epidemiology SECI

Citations(all)

6151

Citations(since 2020)

1961

Cited By

5100

hIndex(all)

38

hIndex(since 2020)

20

i10Index(all)

67

i10Index(since 2020)

44

Email

University Profile Page

Assiut University

Google Scholar

View Google Scholar Profile

Nabiel Mikhail Skills & Research Interests

HIMS

Top articles of Nabiel Mikhail

Title

Journal

Author(s)

Publication Date

Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B

Saudi Journal of Gastroenterology

Khalid Alswat

Riham Soliman

Nabiel NH Mikhail

Necati Örmeci

George N Dalekos

...

2024/3/13

A Prospective Study for Validation of General Evaluation Score for Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis C Patients

Available at SSRN 4120417

Gamal Shiha

Reham Soliman

Nabiel Mikhail

Ayman A Hassan

Mohammed Eslam

...

2023

Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD

European Journal of Gastroenterology & Hepatology

Amir Anushiravani

Khalid Alswat

George N Dalekos

Kalliopi Zachou

Necati Örmeci

...

2023/11/1

Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program

Medical Journal of Viral Hepatitis

Gamal Shiha

AM Metwally

R Soliman

NNH Mikhail

2023/4/26

Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: A prospective observational study

Hepatoma Res

Gamal Shiha

Reham Soliman

Ayman A Hassan

Nabiel NH Mikhail

2022

Reply to: The best predictive model for post-SVR HCC: can it be universal?

Hepatology International

Gamal Shiha

NNH Mikhail

R Soliman

2022/6

Staging practices and breast cancer stage among population-based registries in the MENA region

Cancer Epidemiology

Marion Pineros

Ophira Ginsburg

Karima Bendahhou

Sultan Eser

Wael A Shelpai

...

2022/12/1

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response

Clinics and Research in Hepatology and Gastroenterology

Jessica Azzi

Céline Dorival

Carole Cagnot

Hélène Fontaine

Clovis Lusivika-Nzinga

...

2022/6/1

Development and multicenter validation of FIB‐6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in …

Hepatology Research

Gamal Shiha

Reham Soliman

Nabiel NH Mikhail

Khalid Alswat

Ayman Abdo

...

2022/2

T cell subsets in chronic hepatitis C patients genotype 4 who achieved SVR following DAAs Therapy

bioRxiv

Gamal Shiha

Reham Soliman

Ayman A Hassan

Nabiel NH Mikhail

Ahmed Nabil

...

2022/10/22

Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study

Hepatology International

Gamal Shiha

Nabiel NH Mikhail

Reham Soliman

Ayman Hassan

Mohammed Eslam

2022/2/1

comparison of clinical prediction rules for ruling out cirrhosis in non‐alcoholic fatty liver disease (NAFLD).

Alimentary Pharmacology & Therapeutics

Gamal Shiha

Nabiel Mikhail

Reham Soliman

2022/9

evaluation and proposed re‐classification of HCC prediction model in patients with chronic hepatitis C genotype 4.

Alimentary Pharmacology & Therapeutics

Gamal Shiha

Nabiel NH Mikhail

Reham Soliman

2022/1/15

International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients

Journal of Viral Hepatitis

Gamal Shiha

Reham Soliman

Nabiel NH Mikhail

Fabrice Carrat

Jessica Azzi

...

2022/9

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single‐centre cohort of European cirrhotics.

Liver International

Gamal Shiha

Reham Soliman

Nabiel Mikhail

Mohammed Eslam

2021/5/1

External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs

Journal of Hepatology

Gamal Shiha

Nabiel Mikhail

Reham Soliman

2021/4/1

Multicentre external validation of the GES score for predicting HCC risk in Japanese HCV patients who achieved SVR following DAAs

Liver Cancer International

Kazumichi Abe

Masashi Fujita

Manabu Hayashi

Atsushi Takahashi

Hiromasa Ohira

...

2021/11

Reduced incidence of hepatitis C in 9 villages in rural Egypt: progress towards national elimination goals

Journal of Hepatology

Gamal Shiha

Reham Soliman

Nabiel NH Mikhail

Philippa Easterbrook

2021/2/1

Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk‐based surveillance using pre‐and post‐treatment general evaluation score

Liver International

Gamal Shiha

Reham Soliman

Nabiel Mikhail

Ayman Hassan

Mohammed Eslam

2021/11

Development and multicenter external validation of FIB-6; a novel, machine-learning, simple bedside score to rule out severe liver fibrosis and cirrhosis in patients with …

Gamal Shiha

Reham Soliman

Nabiel Mikhail

Khalid Alswat

Ayman Abdo

...

2021/7/1

See List of Professors in Nabiel Mikhail University(Assiut University)